1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for JAGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2016. Start Trial.
Date Value
September 09, 2026 -99.46%
September 08, 2026 -99.40%
September 04, 2026 -98.97%
September 03, 2026 -98.82%
September 02, 2026 -98.75%
September 01, 2026 -98.72%
August 31, 2026 -98.61%
August 28, 2026 -98.55%
August 27, 2026 -98.60%
August 26, 2026 -98.51%
August 25, 2026 -98.52%
August 24, 2026 -98.55%
August 21, 2026 -98.64%
August 20, 2026 -98.67%
August 19, 2026 -98.62%
August 18, 2026 -98.65%
August 17, 2026 -98.80%
August 14, 2026 -98.74%
August 13, 2026 -99.14%
August 12, 2026 -99.08%
August 11, 2026 -98.97%
August 10, 2026 -98.89%
August 07, 2026 -98.71%
August 06, 2026 -98.79%
August 05, 2026 -98.65%
Date Value
August 04, 2026 -98.67%
August 03, 2026 -98.56%
July 31, 2026 -98.60%
July 30, 2026 -98.61%
July 29, 2026 -98.74%
July 28, 2026 -98.78%
July 27, 2026 -98.72%
July 24, 2026 -98.81%
July 23, 2026 -98.76%
July 22, 2026 -98.42%
July 21, 2026 -98.51%
July 20, 2026 -98.44%
July 17, 2026 -98.40%
July 16, 2026 -98.44%
July 15, 2026 -97.68%
July 14, 2026 -97.41%
July 13, 2026 -97.62%
July 10, 2026 -97.49%
July 09, 2026 -97.43%
July 08, 2026 -97.36%
July 07, 2026 -97.01%
July 06, 2026 -96.89%
July 02, 2026 -96.88%
July 01, 2026 -96.53%
June 30, 2026 -96.60%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Reviva Pharmaceuticals Holdings, Inc. -94.04%
Jupiter Neurosciences, Inc. -97.04%
ANI Pharmaceuticals, Inc. -28.19%
Corcept Therapeutics, Inc. 61.30%
Veru, Inc. -28.53%